Literature DB >> 24071884

Mortality among African American women with sarcoidosis: data from the Black Women's Health Study.

M H Tukey1, J S Berman, D A Boggs, L F White, L Rosenberg, Y C Cozier.   

Abstract

BACKGROUND: Sarcoidosis is a chronic systemic granulomatous disease of unknown etiology that disproportionately affects black females.  Few studies have specifically addressed causes of death in this population.
OBJECTIVES: To assess rates and causes of death among women with sarcoidosis in a prospective cohort study of U.S. black women.
DESIGN: The Black Women's Health Study is a follow-up study of 59,000 U.S. black women aged 21-69 (median age 38) at entry in 1995.  Data on demographic and lifestyle factors and medical conditions, including sarcoidosis, were obtained through biennial questionnaires.  Deaths and causes of death from 1995 through 2009 among study subjects were identified from National Death Index data. We assessed mortality rates among women with and without a history of sarcoidosis.  Poisson regression models were used to estimate age-adjusted mortality rates. Cox proportional-hazards models were used to estimate hazard ratios for mortality and 95% confidence intervals.
RESULTS: A total of 121 deaths occurred among 1,192 women with a history of sarcoidosis and 2813 deaths among women without sarcoidosis.  Mortality was greater at every age among women with sarcoidosis and the overall multivariable-adjusted hazard ratio was 2.44 (95% CI 2.03-2.93, p<0.0001). Of the deaths among women with sarcoidosis, 24.7% were directly attributable to sarcoidosis.
CONCLUSIONS: In the Black Women's Health Study, women with sarcoidosis were more than twice as likely to die as women without the disease, with many of the deaths directly attributable to sarcoidosisSarcoidosis is an important cause of premature death among black women with the disease.

Entities:  

Mesh:

Year:  2013        PMID: 24071884      PMCID: PMC3801105     

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  21 in total

1.  Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study.

Authors:  A P Crawshaw; C J Wotton; D G R Yeates; M J Goldacre; L-P Ho
Journal:  Thorax       Date:  2010-09-13       Impact factor: 9.139

Review 2.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

3.  Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua J Solomon; David Sprunger; Kevin K Brown
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

Review 4.  Epidemiology of sarcoidosis.

Authors:  E A Bresnitz; B L Strom
Journal:  Epidemiol Rev       Date:  1983       Impact factor: 6.222

5.  Clinical characteristics of patients in a case control study of sarcoidosis.

Authors:  R P Baughman; A S Teirstein; M A Judson; M D Rossman; H Yeager; E A Bresnitz; L DePalo; G Hunninghake; M C Iannuzzi; C J Johns; G McLennan; D R Moller; L S Newman; D L Rabin; C Rose; B Rybicki; S E Weinberger; M L Terrin; G L Knatterud; R Cherniak
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

Review 6.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

7.  Sarcoidosis-related mortality in the United States from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua Solomon; David Sprunger; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2011-02-17       Impact factor: 21.405

8.  General and abdominal obesity and risk of death among black women.

Authors:  Deborah A Boggs; Lynn Rosenberg; Yvette C Cozier; Lauren A Wise; Patricia F Coogan; Edward A Ruiz-Narvaez; Julie R Palmer
Journal:  N Engl J Med       Date:  2011-09-08       Impact factor: 91.245

9.  Predicting mortality in patients with sarcoidosis awaiting lung transplantation.

Authors:  Andrew F Shorr; Darcy B Davies; Steven D Nathan
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

10.  Sarcoidosis, race, and short-term outcomes following lung transplantation.

Authors:  Andrew F Shorr; Donald L Helman; Darcy B Davies; Steven D Nathan
Journal:  Chest       Date:  2004-03       Impact factor: 9.410

View more
  14 in total

Review 1.  Disease Burden and Variability in Sarcoidosis.

Authors:  Alicia K Gerke; Marc A Judson; Yvette C Cozier; Daniel A Culver; Laura L Koth
Journal:  Ann Am Thorac Soc       Date:  2017-12

Review 2.  Morbidity and mortality in sarcoidosis.

Authors:  Alicia K Gerke
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

Review 3.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Reumatismo       Date:  2017-05-22

4.  Epidemiology of Sarcoidosis 1946-2013: A Population-Based Study.

Authors:  Patompong Ungprasert; Eva M Carmona; James P Utz; Jay H Ryu; Cynthia S Crowson; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2015-12-22       Impact factor: 7.616

Review 5.  [Sarcoidosis and uveitis : An update].

Authors:  J G Garweg
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

6.  Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013-2014.

Authors:  Patompong Ungprasert; Karn Wijarnpreecha; Wisit Cheungpasitporn; Charat Thongprayoon; Wuttiporn Manatsathit; Paul T Kröner
Journal:  Lung       Date:  2019-02-23       Impact factor: 2.584

Review 7.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

8.  In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012.

Authors:  Susanne Pohle; Florent Baty; Martin Brutsche
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

9.  Sarcoidosis mortality in Sweden: a population-based cohort study.

Authors:  Marios Rossides; Susanna Kullberg; Johan Askling; Anders Eklund; Johan Grunewald; Elizabeth V Arkema
Journal:  Eur Respir J       Date:  2018-02-21       Impact factor: 16.671

10.  Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.

Authors:  Gillian Murtagh; Luke J Laffin; John F Beshai; Francesco Maffessanti; Catherine A Bonham; Amit V Patel; Zoe Yu; Karima Addetia; Victor Mor-Avi; Joshua D Moss; D Kyle Hogarth; Nadera J Sweiss; Roberto M Lang; Amit R Patel
Journal:  Circ Cardiovasc Imaging       Date:  2016-01       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.